Bioconjugate Chemistry
Article
derivatives of NBDCl)2 and long excitation and emission
wavelengths when compared to fluorophores of similar size,
such as coumarins.20 Interestingly, the attachment of a
hydrazine functional group to these dyes results in fluorogenic
derivatives which allow direct detection of carbonyl derivatives
upon formation of the corresponding hydrazone. Reported
fluorogenic and fluorescent hydrazino-NBD derivatives include
7-hydrazino-4-nitrobenzo-2-oxa-1,3,-diazole (NBDH),21 4-
(N,N-dimethylaminosulfonyl)-7-hydrazino-benz-2,1,3-oxadia-
zole (DBDH),22 4,4-aminosulfonyl-7-hydrazino-2,1,3-benzoxa-
diazole (ABDH),22 4-(N,N-dimethylaminosulfonyl)-7-N-meth-
ylhydrazino-benz-2,1,3-oxadiazole (MDBDH),23 4-[2-(N,N-
dimethylamino)ethylaminosulfonyl]-7-N-methylhydrazino-
benz-2,1,3-oxadiazole (DAABD-MHz),24 and N-methyl-4-
hydrazino-7-nitrobenzofurazan (MNBDH).25 Several of these
derivatives are commercially available and have found
application in biological assays,26 as well as the detection of
trace carbonyls in air samples such as automobile exhaust.23
We considered that small molecule labels compatible with
PAL should be of interest for fluorescence microscopy and
quantitation of glycoconjugates. To take advantage of the PAL
strategy, the fluorophore should contain a nucleophilic group
that will react with an aldehyde rapidly in water. Although
hydrazines have been explored for this purpose, we chose to
investigate an amino-oxy-containing fluorophore.8 Herein we
describe the synthesis of a novel amino-oxy fluorophore,
NBDAO (5), which has improved sensitivity over existing dyes
for selective labeling of sialic acid glycoconjugates on live cells.
We contrast the properties of NBDAO to a known carbonyl
reactive fluorophore, NBDH (2).21 We first observed labeling
of cells with a fluorescence microplate reader. Additionally,
NBDAO was used to label a glycoprotein in conjunction with
PAL, followed by fluorescence detection in SDS-PAGE. Finally,
we compared the performance of NBDAO to commercially
available hydrazine dyes NBDH and Bodipy FL hydrazide in
fluorescence microscopy and flow cytometry assays. We
conclude that these dyes can be used as an effective one-step
live-cell labeling strategy for glycoconjugates, and that NBDAO
provides the best level of sensitivity among the dyes tested.
Chloro-7-nitrobenz-[2,1,3-d]-oxadiazole (1) (100 mg, 0.5
mmol, 1 equiv) was dissolved in chloroform (50 mL). A 1%
hydrazine solution (0.77 mL hydrazine in 50 mL methanol)
was then added to the solution and allowed to stir at room
temperature for 1 h. A yellow-brown precipitate was formed
1
and isolated without further purification (104 mg, quant.) H
NMR (400 MHz, D2O): δ 7.04 (d, 1H, 3J = 10.5 Hz), 6.37 (d,
1H, 3J = 10.5 Hz); 13C NMR (100 MHz, D2O): δ 147.6, 145.4,
131.4, 121.9, 120.8, 115.1; IR (microscope): ν = 3378, 3278,
3191, 3051, 2984, 2692, 1618, 1542, 1500, 1465, 1213, 1019,
982, 873, 794 cm−1. ES-HRMS calculated for C5H5N5O3Na:
218.0285, observed: 218.0284.
4-(2-Benzylidenehydrazinyl)-7-nitrobenz-[2,1,3-d]-oxadia-
zole (3). 4-Hydrazinyl-7-nitrobenz-[2,1,3-d]-oxadiazole (2) (25
mg, 0.13 mmol, 1 equiv) was dissolved in methanol (10 mL).
Benzaldehyde (0.13 mL, 1.3 mmol, 10 equiv) was added,
turning the reaction mixture a red color. The product gradually
formed as a dark red-black precipitate and was isolated by
vacuum filtration. Additional product was isolated from the
supernatant after flash column chromatography (EtOAc/
hexanes). The precipitate and column fractions were combined
(27 mg, 74%). 1H NMR (400 MHz, (CD3)2CO): 8.62 (d, 1H,
3J = 8.8 Hz), 8.59 (s, 1H), 7.92−7.79 (m, 2H), 7.56−7.39 (m,
3H), 7.31 (d, 1H, 3J = 8.8 Hz); 13C NMR (100 MHz,
(CD3)2CO): δ 149.9, 145.2, 144.1, 141.0, 137.0, 134.9, 131.6,
129.8, 128.4, 126.0, 102.7; IR (microscope): ν = 3486, 3307,
3219, 3144, 3060, 2955, 1603, 1581, 1515, 1446, 1406, 1295,
1117, 997 cm−1. ES-HRMS calculated for C13H10N5O3:
284.0778, observed: 284.0778. Rf = 0.23 (1:3 EtOAc/hexanes).
Ethyl N-7-nitrobenz-[2,1,3-d]-oxadiazol-4-yloxyacetimi-
date (4). Ethyl N-hydroxyacetimidate (35 mg, 0.34 mmol, 3
equiv) was dissolved in H2O (2 mL). Sodium carbonate (100
mg, 0.94 mmol, 7.5 equiv) was added and the reaction mixture
was allowed to stir for 10 min. 4-Chloro-7-nitrobenz-[2,1,3-d]-
oxadiazole (1) (25 mg, 0.125 mmol, 1 equiv) was then added
and allowed to stir at room temperature for approximately 15
min. The resulting brown-yellow precipitate was isolated by
vacuum filtration without further purification (35 mg, quant.).
1H NMR (300 MHz, CDCl3): δ 8.54 (d, 1H, 3J = 8.4 Hz), 7.25
3
3
(d, 1H, J = 8.4 Hz), 4.27 (q, 2H, J = 6.9 Hz), 2.32 (s, 3H),
1.42 (t, 3H, J = 6.9 Hz); 13C NMR (100 MHz, CDCl3): δ
3
METHODS
■
170.2, 154.3, 144.2, 143.9, 134.6, 129.7, 106.2, 64.4, 15.3, 14.5.
IR (microscope): ν = 3133, 3090, 2999, 2988, 1933, 1713,
1645, 1623, 1537, 1451, 1379, 1164, 997, 854 cm−1. ES-HRMS
calculated for C10H10N4O5Na: 289.0543, observed: 289.0541.
Rf = 0.69 (1:3 EtOAc/hexanes).
General Experimental Methods. Reagents were pur-
chased from commercial sources such as Sigma-Aldrich
(Oakville, Ont) and used without additional purification.
Proton (1H) and carbon (13C) NMR spectra were obtained
on Varian 300, 400, 500, or 700 MHz instruments at room
temperature as noted. Deuterated solvents were obtained from
Cambridge Isotope Laboratories (Andover, MA). Mass
spectrometry was performed using an MS50G positive electron
impact instrument from Kratos Analytical (Manchester, UK)
and a Mariner Biospectrometry positive ion electrospray
instrument from Applied Biosystems (Foster City, CA).
Spectroscopy. Absorbance spectra for all compounds were
collected at room temperature with a Hewlett-Packard (Palo
Alto, CA) model 8453 diode array UV−visible spectropho-
tometer or Varian (Walnut Creek, CA) Cary 50 spectropho-
tometer. Fluorescence spectra for all compounds were collected
at room temperature with a Photon Technology International
model MP1 steady-state fluorimeter. Absorbance and fluo-
rescence measurements were taken using NSG Precision Cells
ES quartz cuvettes (190−2000 nm; Farmingdale, NY).
O-(7-Nitrobenzo-[2,1,3-d]-oxadiazol-4-yl)hydroxylamine
(5, NBDAO). Ethyl N-7-nitrobenz-[2,1,3-d]-oxadiazol-4-yloxya-
cetimidate (4) (250 mg, 0.94 mmol, 1 equiv) was dissolved in
1:1 TFA/water (25 mL) and allowed to stir at room
temperature for 2 h. The TFA was removed in vacuo, and
the resulting aqueous solution was concentrated by lyophiliza-
tion. The product was isolated by flash column chromatography
1
with a dichloromethane mobile phase (94 mg, 55%). H NMR
(700 MHz, CDCl3): δ 8.56 (d, 1H, 3J = 8.4 Hz), 7.40 (d, 1H, 3J
= 8.4 Hz), 6.51 (s, 2H). 13C NMR (175 MHz, CDCl3): δ 156.0,
143.9, 143.5, 134.0, 130.1, 105.7; IR (microscope): ν = 3325,
3255, 3167, 3104, 2918, 2851, 1641, 1588, 1537, 1328, 1083,
997, 729 cm−1. ES-HRMS calculated for C6H4N4O4Na:
219.0125, observed: 219.0127. Rf = 0.25 (1:3 EtOAc/hexanes).
Butan-2-one O-7-nitrobenzo-[2,1,3-d]-oxadiazol-4-yl
oxime (6). O-(7-Nitrobenz-[2,1,3-d]-oxadiazol-4-yl)-
hydroxylamine (5) (27 mg, 0.14 mmol, 1 equiv) was dissolved
Synthesis of Dyes and Model Conjugates. 4-
Hydrazinyl-7-nitrobenz-[2,1,3-d]-oxadiazole (2, NBDH). 4-
364
dx.doi.org/10.1021/bc200276k | Bioconjugate Chem. 2012, 23, 363−371